Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

Finally, the frog pulls in its limbs to prepare for the next jump. Cricket frogs cyclically jump and belly flop their way across water. This high-speed video shows their “porpoising ...

The current iteration of flip phones with foldable screens has come a long way, improving in design, durability and features while dropping in price – the new Razr starts at just $700.

"Flip smartphones are popular for their blend of style, functionality, and nostalgia. Their compact, foldable design saves space, making them convenient for pocket storage. When opened, they offer ...

After hours: January 24 at 7:39:07 p.m. EST ...

1 Day TEVA -0.50% DJIA -0.32% S&P 500 -0.29% Health Care/Life Sciences -0.52% ...

Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone.